Opticyte CEO Lori Arakaki presented at an event sponsored by MTEC | Medical Technology Enterprise Consortium. The event was on innovations that could serve the military, and her presentation focused on how Opticyte’s novel cellular oxygenation monitoring could improve survival from battlefield trauma.
The event was part of The Society of Critical Care Medicine’s (SCCM) annual Critical Care Congress, the premier event in critical care, bringing together a global community of thousands to explore the latest research, groundbreaking technologies, and best practices to improve outcomes for critically ill and injured patients.